Abatacept Versus Adalimumab Head-to-Head

NCT00929864 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

869

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept
DRUG: Adalimumab

Sponsor

Bristol-Myers Squibb